HIV/AIDS Vaccine
HIV preventive vaccine trials in developing countries examined
Published in Vaccine Weekly, April 6th, 2005
According to recent research from South Africa, "HIV treatment for participants who become infected during HIV vaccine trials has been the focus of ethical controversy. The obligations of sponsors to ensure that participants have access to anti-retrovirals have been a particular focus of this debate. This paper presents three arguments that have been made in this regard, and some of their limitations, in anticipation of HIV vaccine trials in South Africa. The first argument is that HIV risk behavior increases in such trials, and HIV...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-04-06)
More Articles from Vaccine Weekly
- Borna Disease
Orf virus protects against Borna disease virus infection of the brain - Cancer Vaccine
Imatinib mesylate overcomes tumor-induced CD4+ T-cell tolerance - Cytomegalovirus Vaccine
Cytomegalovirus DNA vaccine protects against murine cytomegalovirus challenge - HIV/AIDS Vaccine
HIV preclinical interventions in nonhuman primates investigated - HIV/AIDS Vaccine
Rhabdoviral prime-boost induces strong anti-HIV immune responses - Alzheimer Disease
Cerebral hemorrhage dependent on antibody recognition of amyloid beta - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
